Filing metadata

Accession number
0001062993-24-008378
Form type
Form 4
Filer
Acrivon Therapeutics, Inc.
CIK
CIK 1781174
Filed
Apr 15, 2024
Reporting period
Apr 11, 2024
Description
Insider transaction

Explore SEC Filings Hub